Two Sigma Investments’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Two Sigma Investments’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,424	Closed	-$622K	–	2925
2022 Q2	$622K	Buy	5,424 +4,583	+545%	+$537K	﹤0.01%	1734
2022 Q1	$159K	Buy	+841	New	+$195K	﹤0.01%	2371
2021 Q4	–	Sell	-448	Closed	-$150K	–	5032
2021 Q3	$150K	Sell	448 -53	-11%	-$27.2K	﹤0.01%	4023
2021 Q2	$413K	Buy	+501	New	+$388K	﹤0.01%	3253

Other funds holding OMIC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

Revelation Capital Management Sausalito, California $67.4M AUM

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Two Sigma Investments's OMIC Position: Q3 2022 in Review

Two Sigma Investments sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2022, closing a stake of 5,424 shares — an estimated $622K sold.

Two Sigma Investments first reported a position in OMIC in Q2 2021 and held it in 4 quarters. The position peaked at $622K in Q2 2022. 74 funds tracked by Wall St. Rank hold OMIC as of Q3 2022.

Two Sigma Investments reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Two Sigma Investments sold 5,424 Singular Genomics Systems, Inc. Common Stock shares in Q3 2022, an estimated $622K.
Two Sigma Investments first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Two Sigma Investments's Singular Genomics Systems, Inc. Common Stock position peaked at $622K in Q2 2022.
74 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.